Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function
Background: Gender-affirming hormone therapy (GAHT) is used in individuals with gender identity dysphoria to align their secondary sexual characteristics with their affirmed gender. We conducted a systematic review of the literature to explore the mechanisms regarding the effects of GAHT on the vasc...
Saved in:
| Main Authors: | Kirsty A McGinley, Angela K Lucas-Herald, Paul Connelly, Christian Delles |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2025-01-01
|
| Series: | Endocrine Connections |
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/14/2/EC-24-0222.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of gender affirming hormone therapy with testosterone on renal function of assigned female at birth transgender people: a meta-analysis
by: Daniele Tienforti, et al.
Published: (2025-06-01) -
Corrigendum: Review of adult gender transition medications: mechanisms, efficacy measures, and pharmacogenomic considerations
by: Inder Sehgal
Published: (2025-01-01) -
GENDER DISPHORIA: PSYCHIATRIC DIAGNOSIS, EVALUATION AND DOCUMENTATION PROTOCOL
by: Doğan Şahin
Published: (2021-04-01) -
Epigenetic remodeling by sex hormone receptors and implications for gender affirming hormone therapy
by: Den Celestra, et al.
Published: (2025-05-01) -
Effects of gender-affirming hormones on diurnal cortisol concentrations: A prospective study
by: Margot W.L. Morssinkhof, et al.
Published: (2025-07-01)